Matches in SemOpenAlex for { <https://semopenalex.org/work/W2949278321> ?p ?o ?g. }
- W2949278321 endingPage "60" @default.
- W2949278321 startingPage "54" @default.
- W2949278321 abstract "Background and Aim Lenvatinib has been recently approved as a first‐line systematic therapy for patients with advanced hepatocellular carcinoma (HCC) based on the results of the phase 3 clinical trial REFLECT. This trial excluded patients with a history of systemic chemotherapy, bile duct invasion, and Child‐Pugh grade B. We aimed to investigate the efficacy and safety of lenvatinib for these patients and in the real‐world setting. Methods Among patients who were administered lenvatinib for advanced HCC between April and October 2018 in Hokkaido University Hospital and related hospitals, we evaluated those who were followed for more than 2 months and whose treatment response was evaluated via dynamic computed tomography at baseline and 2 months after treatment initiation. Meanwhile, patients were excluded if they had decompensated liver cirrhosis, were followed up less than 2 months, or were not evaluated at 2 months. Patients were also stratified according to compliance with the REFLECT inclusion criteria for further analysis. Results A total of 41 patients were included; more than 50% did not meet the REFLECT inclusion criteria. In total, 5 (12.2%), 20 (48.8%), 12 (29.3%), and 4 (9.3%) showed complete response, partial response, stable disease, and progressive disease, respectively. The objective response rate was 61.2%. The objective response rate and disease control rate were similar between patients who did and did not meet the REFLECT inclusion criteria. Moreover, the safety profile was also similar between the two patient groups. Conclusion Lenvatinib showed high early response rate and tolerability in patients with advanced HCC. Favorable outcomes were similarly observed in patients who did not meet the REFLECT inclusion criteria." @default.
- W2949278321 created "2019-06-27" @default.
- W2949278321 creator A5014225991 @default.
- W2949278321 creator A5016138007 @default.
- W2949278321 creator A5018916073 @default.
- W2949278321 creator A5020231124 @default.
- W2949278321 creator A5024713150 @default.
- W2949278321 creator A5025757104 @default.
- W2949278321 creator A5029167813 @default.
- W2949278321 creator A5031216911 @default.
- W2949278321 creator A5040976202 @default.
- W2949278321 creator A5047266289 @default.
- W2949278321 creator A5048212539 @default.
- W2949278321 creator A5050339468 @default.
- W2949278321 creator A5051255682 @default.
- W2949278321 creator A5052786399 @default.
- W2949278321 creator A5053029290 @default.
- W2949278321 creator A5053862181 @default.
- W2949278321 creator A5057000189 @default.
- W2949278321 creator A5058710999 @default.
- W2949278321 creator A5070753522 @default.
- W2949278321 creator A5072493618 @default.
- W2949278321 creator A5075045544 @default.
- W2949278321 creator A5081579462 @default.
- W2949278321 creator A5083850308 @default.
- W2949278321 creator A5086522106 @default.
- W2949278321 creator A5087097830 @default.
- W2949278321 creator A5091222313 @default.
- W2949278321 date "2019-06-10" @default.
- W2949278321 modified "2023-10-14" @default.
- W2949278321 title "Early response and safety of lenvatinib for patients with advanced hepatocellular carcinoma in a real‐world setting" @default.
- W2949278321 cites W1971837077 @default.
- W2949278321 cites W2046000826 @default.
- W2949278321 cites W2079586464 @default.
- W2949278321 cites W2089114108 @default.
- W2949278321 cites W2102942095 @default.
- W2949278321 cites W2119242310 @default.
- W2949278321 cites W2120967735 @default.
- W2949278321 cites W2151600653 @default.
- W2949278321 cites W2163486683 @default.
- W2949278321 cites W2263171370 @default.
- W2949278321 cites W2482379932 @default.
- W2949278321 cites W2560499218 @default.
- W2949278321 cites W25663774 @default.
- W2949278321 cites W2570752112 @default.
- W2949278321 cites W2581205085 @default.
- W2949278321 cites W2591717879 @default.
- W2949278321 cites W2787358630 @default.
- W2949278321 cites W2802511149 @default.
- W2949278321 cites W2888056309 @default.
- W2949278321 cites W2888117448 @default.
- W2949278321 cites W4211105405 @default.
- W2949278321 cites W4243625103 @default.
- W2949278321 doi "https://doi.org/10.1002/jgh3.12209" @default.
- W2949278321 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7008153" @default.
- W2949278321 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32055698" @default.
- W2949278321 hasPublicationYear "2019" @default.
- W2949278321 type Work @default.
- W2949278321 sameAs 2949278321 @default.
- W2949278321 citedByCount "32" @default.
- W2949278321 countsByYear W29492783212020 @default.
- W2949278321 countsByYear W29492783212021 @default.
- W2949278321 countsByYear W29492783212022 @default.
- W2949278321 countsByYear W29492783212023 @default.
- W2949278321 crossrefType "journal-article" @default.
- W2949278321 hasAuthorship W2949278321A5014225991 @default.
- W2949278321 hasAuthorship W2949278321A5016138007 @default.
- W2949278321 hasAuthorship W2949278321A5018916073 @default.
- W2949278321 hasAuthorship W2949278321A5020231124 @default.
- W2949278321 hasAuthorship W2949278321A5024713150 @default.
- W2949278321 hasAuthorship W2949278321A5025757104 @default.
- W2949278321 hasAuthorship W2949278321A5029167813 @default.
- W2949278321 hasAuthorship W2949278321A5031216911 @default.
- W2949278321 hasAuthorship W2949278321A5040976202 @default.
- W2949278321 hasAuthorship W2949278321A5047266289 @default.
- W2949278321 hasAuthorship W2949278321A5048212539 @default.
- W2949278321 hasAuthorship W2949278321A5050339468 @default.
- W2949278321 hasAuthorship W2949278321A5051255682 @default.
- W2949278321 hasAuthorship W2949278321A5052786399 @default.
- W2949278321 hasAuthorship W2949278321A5053029290 @default.
- W2949278321 hasAuthorship W2949278321A5053862181 @default.
- W2949278321 hasAuthorship W2949278321A5057000189 @default.
- W2949278321 hasAuthorship W2949278321A5058710999 @default.
- W2949278321 hasAuthorship W2949278321A5070753522 @default.
- W2949278321 hasAuthorship W2949278321A5072493618 @default.
- W2949278321 hasAuthorship W2949278321A5075045544 @default.
- W2949278321 hasAuthorship W2949278321A5081579462 @default.
- W2949278321 hasAuthorship W2949278321A5083850308 @default.
- W2949278321 hasAuthorship W2949278321A5086522106 @default.
- W2949278321 hasAuthorship W2949278321A5087097830 @default.
- W2949278321 hasAuthorship W2949278321A5091222313 @default.
- W2949278321 hasBestOaLocation W29492783211 @default.
- W2949278321 hasConcept C126322002 @default.
- W2949278321 hasConcept C143998085 @default.
- W2949278321 hasConcept C197934379 @default.
- W2949278321 hasConcept C2776264508 @default.
- W2949278321 hasConcept C2776694085 @default.
- W2949278321 hasConcept C2777214474 @default.